Asset Dedication LLC’s Novavax NVAX Stock Holding History
Bought
Maintained
Sold
Other funds holding NVAX
SCM
S
Asset Dedication LLC's NVAX Position: Q2 2026 in Review
Asset Dedication LLC held its Novavax (NVAX) position steady in Q2 2026 at 65 shares worth $613. The position accounts for ﹤0.01% of the portfolio, ranked #1142.
Asset Dedication LLC first reported a position in NVAX in Q3 2022 and has held it in 16 quarters since. The position peaked at $1K in Q4 2022. 266 funds tracked by Wall St. Rank hold NVAX as of Q2 2026.
- Asset Dedication LLC held 65 shares of Novavax worth $613 as of Q2 2026.
- Asset Dedication LLC left its Novavax share count unchanged in Q2 2026.
- Novavax made up ﹤0.01% of Asset Dedication LLC's portfolio in Q2 2026, its #1142 holding.
- Asset Dedication LLC first reported a position in Novavax in Q3 2022 and has held it in 16 quarters since.
- Asset Dedication LLC's Novavax position peaked at $1K in Q4 2022.
- 266 funds tracked by Wall St. Rank held Novavax as of Q2 2026.
Based on Asset Dedication LLC's 13F filing for Q2 2026, filed 30 Jul 2026.